We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Department of Anesthesiology

You are here

Intraoperative drug-eluting stent thrombosis in a patient undergoing robotic prostatectomy.

TitleIntraoperative drug-eluting stent thrombosis in a patient undergoing robotic prostatectomy.
Publication TypeJournal Article
Year of Publication2009
AuthorsSharma A, Berkeley A
JournalJ Clin Anesth
Date Published2009 Nov
KeywordsAged, Coronary Artery Disease, Drug-Eluting Stents, Electrocardiography, Fatal Outcome, Humans, Intraoperative Complications, Male, Platelet Aggregation Inhibitors, Prostatectomy, Prostatic Neoplasms, Robotics, Shock, Cardiogenic, Thrombosis, Ventricular Fibrillation

Insertion of drug-eluting stents is one of the strategies for treating patients with coronary artery disease. These patients can be a perioperative challenge in management as they need to be maintained on antiplatelet therapy to prevent stent thrombosis, which puts them at an increased risk for surgical bleeding. Recently revised guidelines on elective surgery following insertion of a drug-eluting stent recommend dual antiplatelet therapy for a period of twelve months. The management of a patient who presented for surgery more than two years after the insertion of a drug-eluting stent, and who developed in-stent thrombosis intraoperatively, is presented.

Alternate JournalJ Clin Anesth
PubMed ID20006260